Cerity Partners OCIO’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Cerity Partners OCIO's DGX Position: Q4 2022 in Review
Cerity Partners OCIO increased its Quest Diagnostics (DGX) stake by 11% in Q4 2022, buying an estimated $144K and bringing the position to 10,233 shares worth $1.6M. The position accounts for 0.05% of the portfolio, ranked #186.
Cerity Partners OCIO first reported a position in DGX in Q1 2018 and has held it in 20 quarters since. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.
- Cerity Partners OCIO held 10,233 shares of Quest Diagnostics worth $1.6M as of Q4 2022.
- Cerity Partners OCIO bought 1,001 Quest Diagnostics shares in Q4 2022, an estimated $144K.
- Quest Diagnostics made up 0.05% of Cerity Partners OCIO's portfolio in Q4 2022, its #186 holding.
- Cerity Partners OCIO first reported a position in Quest Diagnostics in Q1 2018 and has held it in 20 quarters since.
- 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.
Based on Cerity Partners OCIO's 13F filing for Q4 2022, filed 2 Feb 2023.